Brief: Impedimed Says Second Contract Extension Its Sozo Digital Health Platform For Astrazeneca
18/03/2022 01:26
March 18 (Reuters) - ImpediMed Ltd IPD.AX :
* SECOND CONTRACT EXTENSION AND EXPANSION OF ITS SOZO
DIGITAL
HEALTH PLATFORM FOR ASTRAZENECA
* EXTENSION AND EXPANSION OF THIS TRIAL WILL GENERATE AN
ESTIMATED
VALUE OF OVER A$500K
* ANTICIPATES A RANGE OF 250-350 SOZO DEVICES WILL REMAIN
UNDER
ACTIVE CONTRACTS OVER BALANCE OF TRIALS
Source text for Eikon: ID:nASX9SxlFs
Further company coverage: IPD.AX
((Reuters.Briefs@thomsonreuters.com;))